The Right Partner in Crime: Unlocking the Potential of the Anti-EGFR Antibody Cetuximab via Combination With Natural Killer Cell Chartering Immunotherapeutic Strategies

Cetuximab has an established role in the treatment of patients with recurrent/metastatic colorectal cancer and head and neck squamous cell cancer (HNSCC). However, the long-term effectiveness of cetuximab has been limited by the development of acquired resistance, leading to tumor relapse. By contra...

Descripción completa

Detalles Bibliográficos
Autores principales: Baysal, Hasan, De Pauw, Ines, Zaryouh, Hannah, Peeters, Marc, Vermorken, Jan Baptist, Lardon, Filip, De Waele, Jorrit, Wouters, An
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453198/
https://www.ncbi.nlm.nih.gov/pubmed/34557197
http://dx.doi.org/10.3389/fimmu.2021.737311

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453198/
https://www.ncbi.nlm.nih.gov/pubmed/34557197
http://dx.doi.org/10.3389/fimmu.2021.737311

Ejemplares similares